Status:
UNKNOWN
Vitamin B6, B12, Folic Acid and Exercise in Parkinson's Disease
Lead Sponsor:
New York Institute of Technology
Collaborating Sponsors:
Stony Brook University
Conditions:
Parkinson's Disease
Eligibility:
All Genders
50-80 years
Phase:
NA
Brief Summary
This experiment seeks to determine whether individuals with PD will benefit from vitamin B6 (pyridoxine hydrochloride), B12 (cyanocobalamin), and Folic Acid supplementation, whether they will benefit ...
Detailed Description
Individuals with Parkinson's disease (PD) have a higher risk of death from coronary artery disease and stroke (Gorell, Johnson, \& Rybicki, 1994; Postuma \& Lang, 2004). Seventy percent of people with...
Eligibility Criteria
Inclusion
- Medical clearance to perform an exercise tolerance test and training program.
- A diagnosis of PD at stage 2 on the Hoehn and Yahr scale.
Exclusion
- A neurological condition other than PD/
- Anyone who is currently taking any vitamin supplementation.
- Smokers.
- Anyone currently engaged in weight training.
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2010
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01238926
Start Date
May 1 2008
End Date
November 1 2010
Last Update
November 11 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York Institute of Technology, New York College of Osteopathic Medicine, Academic Health Care Center, Adele Smithers Parkinson's Disease Treatment Center
Old Westbury, New York, United States, 11568-8000